Subscribe
Bevacizumab significantly improves survival for patients with recurrent and metastatic cervical cancer
February 7, 2013Patients with advanced, recurrent, or persistent cervical cancer that was not curable with standard treatment who received the drug bevacizumab (Avastin) lived 3.7 months longer than patients who did not receive the drug, according to an interim analysis of a large, randomized clinical trial.
Project SEARCH: An internship program and much more
January 18, 2013When Project SEARCH interns enter the National Institutes of Health campus in Bethesda, Md., they are immediately recognizable—from their matching, sky-blue polo shirts to their smiling faces. Now in its third year, the program, which began at the NIH Clinical Center, offers internships at several NIH institutes, including the National Cancer Institute, to young adults with disabilities, who learn employability skills and gain work experience.
The Living Lab: Navigating into cells
December 6, 2012The Living Lab is an innovative partnership between NIH institutes and private industry, to use cutting-edge electron microscopy to navigate into cells and viruses. Sriram Subramaniam, Ph. D., director of the NIH component of the Living Lab, is pictured holding a model of the three-dimensional structure of a portion of a protein complex from the surface of HIV.
Surveys show time is ripe to deliver on health-related Internet-based tools
November 21, 2012The 2012 version of NCI’s Health Information National Trends Survey (HINTS) shows that Americans expect doctors’ offices, hospitals, and clinics to maintain health information in a sharable, electronic format. Conducted since 2003, HINTS findings help NCI devise better methods of patient communications and shared decision-making.
TARGET: A focus on children’s cancers
October 12, 2012TARGET—Therapeutically Applicable Research to Generate Effective Treatments—is NCI’s effort to use genomic technologies to search for therapeutic targets in cancers that affect infants, children, and adolescents. The adjacent image is a microscopic view of acute lymphoblastic lymphoma, one of the five cancers common to children that TARGET is studying.
Report to the Nation shows cancer death rates dropping
January 7, 2013The Annual Report to the Nation on the Status of Cancer, 1975–2009, shows that overall cancer death rates continued to decline in the U.S. among both men and women, among all major racial and ethnic groups, and for all of the most common cancer sites.
- Sunitinib benefits patients with renal cell carcinomaFebruary 7, 2013
- Bevacizumab improves survival for patients with advanced cervical cancer February 7, 2013
- NIH scientists identify molecular link between metabolism and breast cancerFebruary 5, 2013
- DNA breaks early in replication in B cell cancers January 24, 2013
NCI-designated Cancer Centers: dedicated to research
August 15, 2012Obtaining an NCI designation for a cancer center is usually a years-long process of building — facilities, faculty, and most importantly, a research portfolio — culminated by a rigorous review process. Selection provides recognition of research excellence
- Genomic analysis identifies micro RNA opponent for ovarian cancerFebruary 12, 2013
- Values and techniques shape decisions about PSA screeningFebruary 12, 2013
- Scientists develop mouse model of clear cell sarcomaFebruary 12, 2013
- Hepatic function testing in treatment planning for liver cancerFebruary 11, 2013